Indication
CPEO
1 clinical trial
1 product
Clinical trial
A Phase IIb Open-label, Multi-centre, Extension Study to Explore the Long-term Safety and Efficacy of KH176 in Subjects With a Genetically Confirmed Mitochondrial DNA tRNALeu(UUR) m.3243A>G Mutation Who Have Completed the KHENERGYZE Study KH176-202.Status: Completed, Estimated PCD: 2023-06-01
Product
KH176